{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:51Z","timestamp":1792686231497,"version":"4.5.0"},"reference-count":48,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004954","name":"Augustinus Foundation","doi-asserted-by":"crossref","award":["19-2397"],"award-info":[{"award-number":["19-2397"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002129","name":"Heart Foundation","doi-asserted-by":"publisher","award":["23015"],"award-info":[{"award-number":["23015"]}],"id":[{"id":"10.13039\/100002129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,12]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Atrial fibrillation is highly prevalent in patients on chronic dialysis. It is unclear whether anticoagulant therapy for stroke prevention is beneficial in these patients. Vitamin K-antagonists (VKA) remain the predominant anticoagulant choice. Importantly, anticoagulation remains inconsistently used and a possible benefit remains untested in randomised clinical trials comparing oral anticoagulation with no treatment in patients on chronic dialysis. The Danish Warfarin-Dialysis (DANWARD) trial aims to investigate the safety and efficacy of VKAs in patients with atrial fibrillation on chronic dialysis. The hypothesis is that VKA treatment compared with no treatment is associated with stroke risk reduction and overall benefit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The DANWARD trial is an investigator-initiated trial at 13 Danish dialysis centres. In an open-label randomised clinical trial study design, a total of 718 patients with atrial fibrillation on chronic dialysis will be randomised in a 1:1 ratio to receive either standard dose VKA targeting an international normalised ratio of 2.0\u20133.0 or no oral anticoagulation. Principal analyses will compare the risk of a primary efficacy endpoint, stroke or transient ischaemic attack and a primary safety endpoint, major bleeding, in patients allocated to VKA treatment and no treatment, respectively. The first patient was randomised in October 2019. Patients will be followed until 1 year after the inclusion of the last patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study protocol was approved by the Regional Research Ethics Committee (journal number H-18050839) and the Danish Medicines Agency (case number 2018101877). The trial is conducted in accordance with the Helsinki declaration and standards of Good Clinical Practice. Study results will be disseminated to participating sites, at research conferences and in peer-reviewed journals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration numbers<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03862859\">NCT03862859<\/jats:ext-link>, EUDRA-CT 2018-000484-86 and CTIS ID 2022-502500-75-00.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081961","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:41:11Z","timestamp":1709012471000},"page":"e081961","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol for a randomised controlled trial comparing warfarin with no oral anticoagulation in patients with atrial fibrillation on chronic dialysis: the Danish Warfarin-Dialysis (DANWARD) trial"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct03862859","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7827-1861","authenticated-orcid":false,"given":"Ellen Linnea Freese","family":"Ballegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Lindhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-1718","authenticated-orcid":false,"given":"Morten","family":"Lindhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Daugaard","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Thomsen Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida N\u00f8rager","family":"Tietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Boesby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Camilla","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Maria B\u00f8ggild","family":"Br\u00f8sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Cibulskyte-Ninkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Moesgaard","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Holden","family":"Mose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Dominik","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Skovhede","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne Kodal","family":"Breinholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-8456","authenticated-orcid":false,"given":"Dea Haagensen","family":"Kofod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Bressendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Vilhelm","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theis","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper Niels Furbo","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik L","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Dam Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Bjerring","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Hornum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Rix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"2024022621401301000_14.2.e081961.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.01.024"},{"key":"2024022621401301000_14.2.e081961.2","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2018.01.002","article-title":"US renal data system 2017 annual data report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2024022621401301000_14.2.e081961.3","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019897870"},{"key":"2024022621401301000_14.2.e081961.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2024022621401301000_14.2.e081961.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.06.018"},{"key":"2024022621401301000_14.2.e081961.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.020982"},{"key":"2024022621401301000_14.2.e081961.7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs416"},{"key":"2024022621401301000_14.2.e081961.8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.393"},{"key":"2024022621401301000_14.2.e081961.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.07.044"},{"key":"2024022621401301000_14.2.e081961.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.099606"},{"key":"2024022621401301000_14.2.e081961.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.03.032"},{"key":"2024022621401301000_14.2.e081961.12","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199808000-00005"},{"key":"2024022621401301000_14.2.e081961.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105594"},{"key":"2024022621401301000_14.2.e081961.14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2008.10.005","article-title":"United States renal data system 2008 annual data report abstract","volume":"53","author":"Collins","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2024022621401301000_14.2.e081961.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043229","article-title":"Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype","volume":"7","author":"Schurgers","year":"2012","journal-title":"PLoS One"},{"key":"2024022621401301000_14.2.e081961.16","doi-asserted-by":"publisher","DOI":"10.1038\/386078a0"},{"key":"2024022621401301000_14.2.e081961.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.01.034"},{"key":"2024022621401301000_14.2.e081961.18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"2024022621401301000_14.2.e081961.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"2024022621401301000_14.2.e081961.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011293232201"},{"key":"2024022621401301000_14.2.e081961.21","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90585-W"},{"key":"2024022621401301000_14.2.e081961.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211123272002"},{"key":"2024022621401301000_14.2.e081961.23","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92358-Z"},{"key":"2024022621401301000_14.2.e081961.24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009030319"},{"key":"2024022621401301000_14.2.e081961.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.05.019"},{"key":"2024022621401301000_14.2.e081961.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004777"},{"key":"2024022621401301000_14.2.e081961.27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu334"},{"key":"2024022621401301000_14.2.e081961.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.051"},{"key":"2024022621401301000_14.2.e081961.29","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.477"},{"key":"2024022621401301000_14.2.e081961.30","doi-asserted-by":"publisher","DOI":"10.1159\/000046216"},{"key":"2024022621401301000_14.2.e081961.31","first-page":"33","article-title":"Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin","volume":"2","author":"Lai","year":"2009","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2024022621401301000_14.2.e081961.32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024022621401301000_14.2.e081961.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2024022621401301000_14.2.e081961.34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0037-1621715","article-title":"Direct oral anticoagulants in end-stage renal disease","volume":"44","author":"Klil-Drori","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"2024022621401301000_14.2.e081961.35","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020111566"},{"key":"2024022621401301000_14.2.e081961.36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.054990"},{"key":"2024022621401301000_14.2.e081961.37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A randomized controlled trial comparing apixaban to the vitamin K-antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"key":"2024022621401301000_14.2.e081961.38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2018.05.005","article-title":"Chronic kidney disease and arrhythmias: highlights from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"94","author":"Wanner","year":"2018","journal-title":"Kidney Int"},{"key":"2024022621401301000_14.2.e081961.39","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04550511"},{"key":"2024022621401301000_14.2.e081961.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2024022621401301000_14.2.e081961.41","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394717"},{"key":"2024022621401301000_14.2.e081961.42","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish national Registry of patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2024022621401301000_14.2.e081961.43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bcpt.12610","article-title":"Validity of the prescriber information in the Danish national prescription registry","volume":"119","author":"Rasmussen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2024022621401301000_14.2.e081961.44","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfy104.FO006","article-title":"Use of warfarin in end-stage renal disease and atrial fibrillation: risk of stroke and bleeding - a nationwide cohort study","volume":"33","author":"Carlson","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2024022621401301000_14.2.e081961.45","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2004.029496"},{"key":"2024022621401301000_14.2.e081961.46","unstructured":"European Commission . Clinical investigations: serious adverse event reporting under directives 90\/385\/EEC and 93\/42\/EEC. MEDDEV 2.7 (Revision 3). Guidel Med Devices 2015."},{"key":"2024022621401301000_14.2.e081961.47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2024022621401301000_14.2.e081961.48","unstructured":"ICH-GCP . International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. n.d. Available: https:\/\/www.ich.org\/"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:41:35Z","timestamp":1709012495000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,26]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bmjopen-2023-081961"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081961","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}